Pcv69 - Cost-Effectiveness of Ivabradine as a Pharmacotherapy Option for Patients With Congestive Heart Failure: A Systematic Review

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.616
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Peritoneal Dialysis in Patients With Refractory Congestive Heart Failure: A Systematic Review

CardioRenal Medicine
UrologyCardiovascular MedicineCardiology
2015English

Transitional Care for Patients With Congestive Heart Failure: A Systematic Review and Meta-Analysis

Annals of Family Medicine
Family Practice
2015English

The Cost-Effectiveness of Treatment for Chronic Heart Failure: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

MicroRNA 210 as a Biomarker for Congestive Heart Failure

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2013English

Pnd66 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Cyprus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pnd59 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prognostic Factors in Patients With Congestive Heart Failure

Arquivos Brasileiros de Cardiologia
Cardiovascular MedicineCardiology
1999English

Long-Term Prognosis of Patients With Congestive Heart Failure.

Japanese Circulation Journal
1990English

Congestive Heart Failure

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy